An update on Alzheimer's disease: Immunotherapeutic agents, stem cell therapy and gene editing
出版年份 2021 全文链接
标题
An update on Alzheimer's disease: Immunotherapeutic agents, stem cell therapy and gene editing
作者
关键词
Alzheimer, Immunotherapy, Genome, Stem cell, Monoclonal antibody, CRISPR
出版物
LIFE SCIENCES
Volume 282, Issue -, Pages 119790
出版商
Elsevier BV
发表日期
2021-07-08
DOI
10.1016/j.lfs.2021.119790
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Trends in life expectancy: did the gap between the healthy and the ill widen or close?
- (2020) Anna C. Meyer et al. BMC Medicine
- Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s disease
- (2020) Sahil Khan et al. Current Neuropharmacology
- Biochemical Markers in Alzheimer’s Disease
- (2020) Alessandro Rabbito et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Aducanumab, gantenerumab, BAN2401, and ALZ-801—the first wave of amyloid-targeting drugs for Alzheimer’s disease with potential for near term approval
- (2020) Martin Tolar et al. Alzheimers Research & Therapy
- Treatment Combinations for Alzheimer’s Disease: Current And Future Pharmacotherapy Options
- (2019) Jeffrey L. Cummings et al. JOURNAL OF ALZHEIMERS DISEASE
- In vivo neuronal gene editing via CRISPR–Cas9 amphiphilic nanocomplexes alleviates deficits in mouse models of Alzheimer’s disease
- (2019) Hanseul Park et al. NATURE NEUROSCIENCE
- On the Etiopathogenesis and Pathophysiology of Alzheimer’s Disease: A Comprehensive Theoretical Review
- (2019) Tobore Onojighofia Tobore JOURNAL OF ALZHEIMERS DISEASE
- Understanding the Amyloid Hypothesis in Alzheimer’s Disease
- (2019) Giulia Paroni et al. JOURNAL OF ALZHEIMERS DISEASE
- The Alzheimer Precision Medicine Initiative
- (2019) Harald Hampel et al. JOURNAL OF ALZHEIMERS DISEASE
- Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype
- (2019) Lisa Vermunt et al. Alzheimers & Dementia
- Target Engagement in an Alzheimer Trial: Crenezumab Lowers Aβ Oligomers in CSF
- (2019) Ting Yang et al. ANNALS OF NEUROLOGY
- Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial
- (2019) Adam L Boxer et al. LANCET NEUROLOGY
- The viral protein corona directs viral pathogenesis and amyloid aggregation
- (2019) Kariem Ezzat et al. Nature Communications
- Aging and Alzheimer's disease pathology
- (2019) Renpei Sengoku NEUROPATHOLOGY
- Biomarker definitions and their applications
- (2018) Robert M Califf EXPERIMENTAL BIOLOGY AND MEDICINE
- Precision Medicine
- (2018) Alan R. Weil HEALTH AFFAIRS
- Tau Immunotherapies for Alzheimer’s Disease and Related Tauopathies: Progress and Potential Pitfalls
- (2018) Einar M. Sigurdsson JOURNAL OF ALZHEIMERS DISEASE
- Specific glycosaminoglycan chain length and sulfation patterns are required for cell uptake of tauversusα-synuclein and β-amyloid aggregates
- (2018) Barbara E. Stopschinski et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer’s disease
- (2018) Paul J. Cheng-Hathaway et al. Molecular Neurodegeneration
- Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
- (2018) Melanie D. Sweeney et al. Nature Reviews Neurology
- Adeno-Associated Viral Vector (Serotype 2)–Nerve Growth Factor for Patients With Alzheimer Disease
- (2018) Michael S. Rafii et al. JAMA Neurology
- STIM1 deficiency is linked to Alzheimer’s disease and triggers cell death in SH-SY5Y cells by upregulation of L-type voltage-operated Ca2+ entry
- (2018) Carlos Pascual-Caro et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- The Trem2 R47H Alzheimer’s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans
- (2018) Xianyuan Xiang et al. Molecular Neurodegeneration
- Disruption of the psychiatric risk gene Ankyrin 3 enhances microtubule dynamics through GSK3/CRMP2 signaling
- (2018) Jacob C. Garza et al. Translational Psychiatry
- Clusterin Is Required for β-Amyloid Toxicity in Human iPSC-Derived Neurons
- (2018) Jacqueline P. Robbins et al. Frontiers in Neuroscience
- The antimicrobial protection hypothesis of Alzheimer's disease
- (2018) Robert D. Moir et al. Alzheimers & Dementia
- Altered γ-Secretase Processing of APP Disrupts Lysosome and Autophagosome Function in Monogenic Alzheimer’s Disease
- (2018) Christy O.Y. Hung et al. Cell Reports
- Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer’s Disease
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CRISPR Transcriptional Activation Analysis Unmasks an Occult γ-Secretase Processivity Defect in Familial Alzheimer’s Disease Skin Fibroblasts
- (2017) Keiichi Inoue et al. Cell Reports
- Antibody Therapeutics Targeting Aβ and Tau
- (2017) Gilbert Gallardo et al. Cold Spring Harbor Perspectives in Medicine
- CRISPR/Cas9-Correctable mutation-related molecular and physiological phenotypes in iPSC-derived Alzheimer’s PSEN2 N141I neurons
- (2017) Maitane Ortiz-Virumbrales et al. Acta Neuropathologica Communications
- Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients
- (2016) Eric R. Siemers et al. Alzheimers & Dementia
- Genomic variants, genes, and pathways of Alzheimer's disease: An overview
- (2016) Adam C. Naj et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Extracellular Tau Paired Helical Filaments Differentially Affect Tau Pathogenic Mechanisms in Mitotic and Post-Mitotic Cells: Implications for Mechanisms of Tau Propagation in the Brain
- (2016) Merina Varghese et al. JOURNAL OF ALZHEIMERS DISEASE
- Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer’s Disease: Analytical and Diagnostic Characterization
- (2016) Piotr Lewczuk et al. JOURNAL OF ALZHEIMERS DISEASE
- PPARγ-coactivator-1α gene transfer reduces neuronal loss and amyloid-β generation by reducing β-secretase in an Alzheimer’s disease model
- (2016) Loukia Katsouri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The case for rejecting the amyloid cascade hypothesis
- (2015) Karl Herrup NATURE NEUROSCIENCE
- Dopaminergic Modulation of Cortical Plasticity in Alzheimer’s Disease Patients
- (2014) Giacomo Koch et al. NEUROPSYCHOPHARMACOLOGY
- Herpes virus in Alzheimer's disease: relation to progression of the disease
- (2013) Ilaria Carbone et al. NEUROBIOLOGY OF AGING
- Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
- (2012) Robert Howard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab
- (2011) Susanne Ostrowitzki ARCHIVES OF NEUROLOGY
- APP dimer formation is initiated in the endoplasmic reticulum and differs between APP isoforms
- (2011) Simone Isbert et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
- (2011) Eric Karran et al. NATURE REVIEWS DRUG DISCOVERY
- Stem cells for the treatment of neurodegenerative diseases
- (2011) Elise Dantuma et al. Stem Cell Research & Therapy
- Biodemography of human ageing
- (2010) James W. Vaupel NATURE
- Adult neural stem cells in the mammalian central nervous system
- (2009) Dengke K Ma et al. CELL RESEARCH
- Involvement of ROS in BBB dysfunction
- (2009) Pamela B. L. Pun et al. FREE RADICAL RESEARCH
- Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study
- (2008) P Lewczuk et al. MOLECULAR PSYCHIATRY
- Neural Stem Cells Improve Learning and Memory in Rats with Alzheimer’s Disease
- (2008) Shuliang Wu et al. PATHOBIOLOGY
- Genetic modification of stem cells for transplantation
- (2007) M. Ian Phillips et al. ADVANCED DRUG DELIVERY REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started